(Q46853249)

25 December 2017

meta-analysis

0 references

title

Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects (English)

1 reference

25 December 2017

author name string

Mona Darwish

1

1 reference

25 December 2017

Mary Kirby

2

1 reference

25 December 2017

Philmore Robertson

3

1 reference

25 December 2017

Edward T Hellriegel

4

1 reference

25 December 2017

publication date

1 January 2008

1 reference

25 December 2017

Clinical Pharmacokinetics

published in

1 reference

25 December 2017

volume

47

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

61-74

1 reference

25 December 2017

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea

cites work

1 reference

12 December 2020

Clinical pharmacokinetic profile of modafinil

1 reference

12 December 2020

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

1 reference

12 December 2020

Modafinil for excessive sleepiness associated with shift-work sleep disorder

1 reference

12 December 2020

Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin.

1 reference

12 December 2020

Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss

1 reference

12 December 2020

The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study

1 reference

12 December 2020

Effect of modafinil at steady state on the single-dose pharmacokinetic profile of warfarin in healthy volunteers

1 reference

12 December 2020

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy

1 reference

12 December 2020

A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers

1 reference

12 December 2020

In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil

1 reference

12 December 2020

Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects.

1 reference

12 December 2020

Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers

1 reference

12 December 2020

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group

1 reference

12 December 2020

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

1 reference

12 December 2020

Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults

1 reference

12 December 2020

Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome

1 reference

12 December 2020

Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome

1 reference

12 December 2020

10.2165/00003088-200847010-00006

Identifiers

DOI

1 reference

25 December 2017

Dimensions Publication ID

1021353255

0 references

1 reference

25 December 2017